UAB "LV PHARMA" Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 8,670 |
| 4,335 |
| 708 |
| -708 |
| -354 |
| -7.34 |
| -8.17 |
| 673 |
| 2 |
| 447 |
| 228 |
| 2024 |
|---|
| 9,460 |
| 4,730 |
| 99 |
| 99 |
| 50 |
| 1.63 |
| 1.05 |
| 772 |
| 0 |
| 447 |
| 325 |
| 2025 |
|---|
| 13,160 |
| 8,773 |
| 405,369 |
| 405,124 |
| 270,083 |
| 36.38 |
| 3,078.45 |
| 405,896 |
| 512 |
| 10 |
| 406,398 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 13,160 |
| 8,773 |
| 405,369 |
| 405,124 |
| 270,083 |
| 36.38 |
| 3,078.45 |
| 405,896 |
| 512 |
| 10 |
| 406,398 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
13,160 €39 % *
Sales per employee (€)
8,773 €85 % *
Profit before tax (€)
405,369 €409,364 % *
Net Profit (€)
405,124 €409,116 % *
Profit per employee (€)
270,083 €540,066 % *
Total profitability (%)
36.38 %2,131.90 % *
Net profitability (%)
3,078.45 %293,085.71 % *
Equity (€)
405,896 €52,477 % *
Amounts Payable And Liabilities (€)
512 €- *
Non-current Assets (€)
10 €-98 % *
CurrentAssets (€)
406,398 €124,946 % *
